Literature DB >> 23034021

The past 200 years in diabetes.

Kenneth S Polonsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23034021     DOI： 10.1056/NEJMra1110560

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

1.  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.

Authors:  Shuai Xue; Jianli Yin; Jiawei Shao; Yuanhuan Yu; Linfeng Yang; Yidan Wang; Mingqi Xie; Martin Fussenegger; Haifeng Ye
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 2.  The emerging role of epigenetics in cardiovascular disease.

Authors:  Charbel Abi Khalil
Journal:  Ther Adv Chronic Dis       Date:  2014-07       Impact factor: 5.091

Review 3.  Linking community resources in diabetes care: a role for technology?

Authors:  Elizabeth L Tung; Monica E Peek
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

4.  Deteriorated functional and structural brain networks and normally appearing functional-structural coupling in diabetic kidney disease: a graph theory-based magnetic resonance imaging study.

Authors:  Yun Fei Wang; Ping Gu; Jiong Zhang; Rongfeng Qi; Michael de Veer; Gang Zheng; Qiang Xu; Ya Liu; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

5.  Fallacy of yes or no choices.

Authors:  Robert M Bernstein
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

6.  What's fueling the biotech engine-2011 to 2012.

Authors:  Saurabh Rob Aggarwal
Journal:  Nat Biotechnol       Date:  2012-12       Impact factor: 54.908

Review 7.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

Review 8.  Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Authors:  Gerald H Tomkin
Journal:  World J Diabetes       Date:  2014-10-15

9.  Premixed insulin regimens in type 2 diabetes: pros.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito; Dario Giugliano
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

10.  Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway.

Authors:  Haiyan Liu; Ali Javaheri; Rebecca J Godar; John Murphy; Xiucui Ma; Nidhi Rohatgi; Jana Mahadevan; Krzysztof Hyrc; Paul Saftig; Connie Marshall; Michael L McDaniel; Maria S Remedi; Babak Razani; Fumihiko Urano; Abhinav Diwan
Journal:  Autophagy       Date:  2017-11-25       Impact factor: 16.016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.